A study investigating the role of solute carrier family of membrane transporters in ovarian cancer revealed the down-regulation of SLC38A10 in ovarian cancer tissues when compared to normal ovarian tissues (Sun et al., 2020). Here, SLC38A10 is linked to ovarian carcinoma.